Insmed (INSM) Long-Term Debt Issuances (2012 - 2022)

Insmed (INSM) posted quarterly Long-Term Debt Issuances of $350.0 million for Q4 2022, down 11.39% quarter-over-quarter from $395.0 million in Q4 2018.

Insmed (INSM) Long-Term Debt Issuances (2012 - 2022) Analysis & Trends

Insmed's Long-Term Debt Issuances history runs 4 years deep, the most recent figure standing at $350.0 million for Q4 2022.

  • In Q4 2022, Long-Term Debt Issuances changed N/A year-over-year to $350.0 million; the TTM figure through Dec 2022 stood at $350.0 million (changed N/A YoY), while the FY2024 annual figure was $150.0 million, changed N/A from the prior year.
  • Long-Term Debt Issuances for Q4 2022 stood at $350.0 million, down from $395.0 million in the prior quarter.
  • The five-year high for Long-Term Debt Issuances was $450.0 million in Q1 2018, with the low at -$395.0 million in Q2 2018.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Debt Issuances (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn -
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn -
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn -
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -675,522.58
7 Royalty Pharma 33.72 Bn 35.84 Bn - -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn -
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn -
10 Roivant Sciences 26.16 Bn 26.85 Bn 1.16 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2022 350.00 Mn
Dec 31, 2022 350.00 Mn
Dec 31, 2018 395.00 Mn
Dec 31, 2018 395.00 Mn
Jun 30, 2018 -395.00 Mn
Jun 30, 2018 -395.00 Mn
Mar 31, 2018 450.00 Mn
Mar 31, 2018 450.00 Mn
Dec 31, 2016 20.00 Mn
Dec 31, 2016 20.00 Mn
Dec 31, 2012 10.27 Mn
Dec 31, 2012 10.27 Mn